1?reslandT, BemelmanWA, SampietroGM, et al. European evidence based consensus on surgery for ulcerative colitis[J]. J Crohns Colitis, 2015, 9(1):4-25.DOI: 10.1016/j.crohns.2014.08.012.
3EadenJA, AbramsKR, MayberryJF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis[J]. Gut, 2001,48(4):526-535.
4DignassA, EliakimR, MagroF,et al.Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis[J]. J Crohns Colitis, 2012,6(10):965-990.DOI: 10.1016/j.crohns.2012.09.003.
5FazioVW, KiranRP, RemziFH,et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3 707 patients[J]. Ann Surg, 2013,257(4):679-685.DOI: 10.1097/SLA.0b013e31827d99a2.
6LovegroveRE, ConstantinidesVA, HeriotAG,et al. A comparison of hand-sewn versus stapled ileal pouch anal anastomosis (IPAA) following proctocolectomy: a meta-analysis of 4 183 patients[J]. Ann Surg, 2006,244(1):18-26.DOI: 10.1097/01.sla.0000225031.15405.a3.
7SelvasekarCR, CimaRR, LarsonDW,et al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis[J]. J Am Coll Surg, 2007,204(5):956-963. DOI: 10.1016/j.jamcollsurg.2006.12.044.
8MorIJ, VogelJD, da LuzMoreira, et al. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy [J]. Dis Colon Rectum, 2008,51(8):1202-1207.DOI: 10.1007/s10350-008-9364-7.
9DelaneyCP, ChangE, SenagoreAJ, et al. Clinical outcomes and resource utilization associated with laparoscopic and open colectomy using a large national database[J]. Ann Surg, 2008,247(5):819-824. DOI: 10.1097/SLA.0b013e31816d950e.
